# PHASE 6 --- STAGE 1 → STAGE 2 COMPLETENESS AUDIT v0.1

Status: PASS --- NO ADDITIONAL HIDDEN DEPENDENCY IDENTIFIED Date:
2026-08-15 Scope: Transition from CER/Webapp PP-0002 controlled path to
the approved Stage 2 end-state.

## 1. Audit question

Identify any genuine dependency required to reach BOTH approved Stage 2
end goals that is not already represented in the current workflow:

1.  Browser → Controlled Chat UI → real chatbot interaction.
2.  Controlled evaluation coverage of all 239 PP.

Do not add best-practice requirements, new governance layers, PP
re-review, metadata cleanup, remediation loops, or unapproved batch
architecture.

## 2. Source basis reviewed

The audit used the supplied Phase 6 handover, CER Run #001 evidence,
Webapp Controlled Trial #001 evidence, Project Status v3.0, Project
Roadmap v2.0, Repository Map v1.6, V6-B20 readiness record, V6-B21
Pre-Execution QA record, Stage 2 S2-A→S2-D approved decisions,
evaluation manifest, evidence-capture reconciliation/operational check,
cleanup reconciliation, and Stage 2 Pre-Execution QA.

## 3. Completeness findings

### 3.1 Controlled Chat UI

Status: REQUIRED / ALREADY IDENTIFIED

The handover explicitly states that the current system has FastAPI +
Swagger + POST /cer/evaluate, but no custom chatbot UI, browser chat
experience, or multi-PP navigation.

No hidden prerequisite beyond implementing and operationally verifying
the already-approved S2-B contract was identified.

### 3.2 239-PP controlled evaluation

Status: REQUIRED / ALREADY IDENTIFIED

S2-C and S2-D already define: - 239 PP; - 239 primary cases; - frozen
manifest; - controlled execution; - evidence per case; - coverage
reconciliation.

No additional evaluation architecture or batch method is required by the
approved scope.

### 3.3 Evidence capture

Status: SATISFIED

Evidence-capture reconciliation and operational check are PASS. The
mechanism supports Case ID, PP ID, expected/observed behavior,
timestamp, run/trace linkage, system baseline context, outcome, safety,
evidence/provenance and review state.

### 3.4 Gold PP eligibility/content

Status: SATISFIED / CLOSED

All 239 PP are explicitly approved as Gold PP / eligible. No further PP
eligibility/content gate is required for this Stage 2 workflow.

### 3.5 Stage 1 CER/Webapp milestones

Status: SATISFIED / CLOSED

CER Run #001 and Webapp Trial #001 remain PASS/CLOSED. No reopen is
required.

### 3.6 Execution baseline

Status: REQUIRED / ALREADY REPRESENTED

B20/B21 explicitly require an actual Phase 6 system-under-validation
baseline to be frozen and verified before execution: repository/commit,
runtime, configuration, knowledge baseline, evidence baseline and safety
configuration.

This is not a new requirement. It is already part of the locked Phase 6
readiness architecture.

### 3.7 Knowledge/evidence/safety baseline

Status: REQUIRED / ALREADY REPRESENTED

B21 explicitly requires the exact knowledge/evidence state and safety
configuration to be identified/frozen before execution.

This is a pre-execution artifact/readiness task, not a new decision.

### 3.8 Human evaluator package

Status: NOT REQUIRED for the approved Stage 2 controlled-evaluation
method unless a human-evaluated validation domain is added.

The approved S2-C method is controlled execution of 239 cases; it does
not silently add formal human validation.

### 3.9 Clinical validation

Status: DEFERRED / NOT A BLOCKER FOR THIS TECHNICAL END-STATE

VC-CLIN remains MISSING --- REQUIRES SOURCE / CLINICAL INPUT. This does
not need to be solved to achieve the approved controlled Chat UI +
239-PP controlled-evaluation objective.

## 4. Audit conclusion

NO ADDITIONAL HIDDEN REQUIRED DEPENDENCY IDENTIFIED.

The Stage 1 → Stage 2 transition is complete enough to proceed without
another decision batch.

The only remaining work is execution of already-approved
objectives/readiness items:

A. Implement and operationally verify the Controlled Chat UI. B.
Reconcile and freeze the 239-case manifest. C. Freeze/verify the actual
Phase 6 execution baseline required by already-locked B20/B21. D. Return
to Pre-Execution QA and GO/NO-GO. E. Execute both approved end-state
surfaces: - Browser Controlled Chat UI E2E - 239-PP controlled
evaluation F. Reconcile evidence and confirm final coverage + Chat UI
E2E evidence.

## 5. Explicit non-actions

Do NOT: - reopen Gold PP; - reopen CER #001; - reopen Webapp Trial
#001; - create another governance decision batch; - invent a new
batch-evaluation architecture; - create an additional PP-validation
loop; - modify governance metadata merely to satisfy a downstream
gate; - treat technical controlled evaluation as clinical validation.

## 6. Recommended immediate sequence

Current: Pre-Execution QA = NO-GO.

Next: 1. Controlled Chat UI implementation / operational verification.
2. Manifest state reconciliation + freeze. 3. Explicit Phase 6
execution-baseline freeze/verification. 4. Pre-Execution QA rerun. 5.
GO/NO-GO. 6. Browser Chat UI E2E + 239-PP controlled evaluation. 7.
Final evidence/coverage reconciliation and Phase 6 closeout.

No additional decision batch is required unless a genuine dependency
appears that changes an already-approved contract.
